Literature DB >> 34495368

Laser speckle flowgraphy findings in focal scleral nodule.

Yui Yamashita1, Michiyuki Saito2, Kiriko Hirooka1, Susumu Ishida1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34495368      PMCID: PMC8786776          DOI: 10.1007/s00417-021-05391-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
Dear Editor. Focal scleral nodule (FSN), renamed by Fung et al. in 2020 [1], is characterized by the partial elevation of the sclera and a solitary yellowish-white spot with clear boundaries. In the FSN lesion, the choroidal circulation may be locally impaired given previously reported hypofluorescence on indocyanine green angiography (ICGA) and nonperfusion of choriocapillaris on optical coherence tomography angiography [1]. To date, surveying macular choroidal blood flow using laser speckle flowgraphy (LSFG) has played an important role in elucidating the pathophysiology of various fundus diseases [2-8]; however, the LSFG findings of FSN has not been reported so far. Here, we report the LSFG findings in 2 FSN cases. We would like to describe 2 cases. Our first case was a 56-year-old woman who was found to have an abnormality in her right fundus. Her medical and family history was unremarkable. The patient’s best-corrected visual acuity (BCVA) was 20/20 OD. Funduscopic examination revealed an orange lesion of less than two-disc diameter on the inferonasal site of the macula (Fig. 1a). Fluorescein angiography (FA) showed scattered hypofluorescence and surrounding hyperfluorescence (Fig. 1c) in the early phase followed by granular enhancement (Fig. 1d). ICGA showed hypofluorescence in the early phase (Fig. 1e) and surrounding slight hyperfluorescence in the late phase (Fig. 1f). On enhanced depth imaging optical coherence tomography (EDI-OCT), the sclera was elevated with the overlying choroid thinned to 20 μm (Fig. 1g), whereas the central choroidal thickness was 144 μm. B-mode echography showed no acoustic shadow (Fig. 1h). Contrast-enhanced MRI of the head and orbit (Fig. 1i), gallium scintigraphy, and blood tests showed no abnormal systemic or ocular findings. The patient was diagnosed with FSN and followed up without treatment. Five years later, the yellowish-white lesion and surrounding orange halo became funduscopically more evident than at the first visit (Fig. 1b).
Fig. 1

Images of the right eye in a patient (Case 1) with focal scleral nodule (FSN). a The fundus photograph at the initial visit showing an orange lesion with well-defined choroidal vessels less than the two-disc diameter at the inferonasal site of the macula. b The FSN lesion was yellowish-white, and the surrounding orange halo became evident 5 years later. c Early-phase fluorescein angiography (FA) shows scattered hypofluorescence and surrounding hyperfluorescence. d The hyperfluorescence turned to granular enhancement in the late phase of FA. e Early-phase indocyanine green angiography showing hypofluorescence at the lesion. f The hypofluorescence persisted with a new surrounding hyperfluorescence in the late phase. g Enhanced depth imaging optical coherence tomography showing the elevation of the sclera, with the overlying choroid thinned to 20 μm. h B-mode echography showing an elevated lesion (white arrow), but without acoustic shadow suggestive of calcification. i Contrast-enhanced MRI of the orbit shows no abnormal findings, including orbital tumors. j The laser speckle flowgraphy color map 1 year after the initial visit showing localized cooler color (white arrowheads) corresponding to the FSN lesion, indicating blood flow impairment

Images of the right eye in a patient (Case 1) with focal scleral nodule (FSN). a The fundus photograph at the initial visit showing an orange lesion with well-defined choroidal vessels less than the two-disc diameter at the inferonasal site of the macula. b The FSN lesion was yellowish-white, and the surrounding orange halo became evident 5 years later. c Early-phase fluorescein angiography (FA) shows scattered hypofluorescence and surrounding hyperfluorescence. d The hyperfluorescence turned to granular enhancement in the late phase of FA. e Early-phase indocyanine green angiography showing hypofluorescence at the lesion. f The hypofluorescence persisted with a new surrounding hyperfluorescence in the late phase. g Enhanced depth imaging optical coherence tomography showing the elevation of the sclera, with the overlying choroid thinned to 20 μm. h B-mode echography showing an elevated lesion (white arrow), but without acoustic shadow suggestive of calcification. i Contrast-enhanced MRI of the orbit shows no abnormal findings, including orbital tumors. j The laser speckle flowgraphy color map 1 year after the initial visit showing localized cooler color (white arrowheads) corresponding to the FSN lesion, indicating blood flow impairment The LSFG color map of mean blur rate (MBR) showed localized cooler color at the lesion (white arrowheads, MBR = 4.6) than at the macula (black arrowheads, MBR = 7.7), indicating blood flow was disrupted in the FSN site (Fig. 1j). Our second case was a 56-year-old woman who was referred to our clinic because of a yellowish-white lesion in her left macula. Past medical and family history was unremarkable. BCVA was 20/16 OS. The fundus and other findings were similar to those in Case 1 (Fig. 2a–i), but the elevation was closer to the macula and steeper. Late-phase FA showed hyperfluorescence across the fovea, indicating retinal pigment epithelial damage (Fig. 2d).
Fig. 2

Images of the left eye in a patient (Case 2) with focal scleral nodule (FSN). a The fundus photograph at the initial visit showing a whitish-yellow lesion of about one-disc diameter with an orange boundary neighboring the fovea. b The lesion and surrounding orange halo became more evident in the fundus photograph 5 years later. c Early-phase fluorescein angiography (FA) showing window defects corresponding to retinal pigment epithelium atrophy around the whitish-yellow lesion. d The hyperfluorescence was enhanced in the late phase of FA. e Early-phase indocyanine green angiography showing low fluorescence at the lesion. f The hypofluorescence lesion persisted in the late phase. g Enhanced depth imaging optical coherence tomography showing the elevation of the sclera (white arrow), with the choroid compressed compared to the other parts of the choroid. h B-mode echography showing an elevated lesion (white arrow) with no acoustic shadow. i Contrast CT of the orbit showing no abnormal findings. j The laser speckle flowgraphy color map 3 months after the initial visit showing apparent solitary cooler color (white arrowheads) corresponding to the lesion

Images of the left eye in a patient (Case 2) with focal scleral nodule (FSN). a The fundus photograph at the initial visit showing a whitish-yellow lesion of about one-disc diameter with an orange boundary neighboring the fovea. b The lesion and surrounding orange halo became more evident in the fundus photograph 5 years later. c Early-phase fluorescein angiography (FA) showing window defects corresponding to retinal pigment epithelium atrophy around the whitish-yellow lesion. d The hyperfluorescence was enhanced in the late phase of FA. e Early-phase indocyanine green angiography showing low fluorescence at the lesion. f The hypofluorescence lesion persisted in the late phase. g Enhanced depth imaging optical coherence tomography showing the elevation of the sclera (white arrow), with the choroid compressed compared to the other parts of the choroid. h B-mode echography showing an elevated lesion (white arrow) with no acoustic shadow. i Contrast CT of the orbit showing no abnormal findings. j The laser speckle flowgraphy color map 3 months after the initial visit showing apparent solitary cooler color (white arrowheads) corresponding to the lesion On LSFG, the lesion showed a cooler color (Fig. 2j white arrowheads, MBR = 3.3) than the macula (black arrowheads, MBR = 10.2), indicating blood flow reduction in the FSN site. Five years later, the lesion became more apparent than at the first visit (Fig. 2b). Since the yellowish-white lesion in this disease was once considered an inflammatory disease of the choroid, Hong et al. named it unifocal helicoid choroiditis in 1997 [9], and Shields et al. solitary idiopathic choroiditis in 2002 [10]. However, recent EDI-OCT findings prompted Fung et al. to rename these lesions to FSN, reporting that these lesions originate from the sclera and not the choroid [1]. In both cases of this report, the cooler LSFG color showed a focal reduction in blood flow. It is noteworthy that the LSFG findings were strictly localized in the lesion. Conversely, in inflammatory diseases such as punctate inner choroidopathy, whose primary condition is choroiditis, LSFG shows reductions in blood flow beyond the visible area of involvement on clinical exam [7], whereas in FSN, reduction in blood flow on LSFG is noted only in the area of involvement on clinical exam. The localized blood flow reduction in LSFG is a finding supporting the pathophysiology of FSN, a primary scleral elevation, and the resultant decrease in choroidal blood flow due to mechanical compression of the choroid.
  10 in total

1.  Unifocal helioid choroiditis.

Authors:  P H Hong; L M Jampol; D G Dodwell; N F Hrisomalos; A T Lyon
Journal:  Arch Ophthalmol       Date:  1997-08

2.  Increased choroidal blood flow velocity with regression of acute posterior multifocal placoid pigment epitheliopathy.

Authors:  Kiriko Hirooka; Wataru Saito; Michiyuki Saito; Yuki Hashimoto; Shohei Mori; Kousuke Noda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2016-03-28       Impact factor: 2.447

3.  Focal Scleral Nodule: A New Name for Solitary Idiopathic Choroiditis and Unifocal Helioid Choroiditis.

Authors:  Adrian T Fung; Sebastian M Waldstein; Orly Gal-Or; Marco Pellegrini; Chiara Preziosa; Jerry A Shields; R Joel Welch; Rosa Dolz-Marco; David Sarraf; Aaron Nagiel; Robert Lalane; Jesse J Jung; Nicola G Ghazi; Prithvi Ramtohul; Jennifer J Arnold; Yoichi Sakurada; Netan Choudhry; Chandrakumar Balaratnasingam; K Bailey Freund; Carol L Shields
Journal:  Ophthalmology       Date:  2020-04-22       Impact factor: 12.079

4.  Laser Speckle Flowgraphy Findings in a Patient with Choroidal Macrovessel.

Authors:  Keiji Kataoka; Satoru Kase; Kousuke Noda; Susumu Ishida
Journal:  Ophthalmol Retina       Date:  2020-06-18

5.  Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy.

Authors:  Michiyuki Saito; Kousuke Noda; Wataru Saito; Kiriko Hirooka; Yuki Hashimoto; Susumu Ishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-14       Impact factor: 3.117

6.  Solitary idiopathic choroiditis: the Richard B. Weaver lecture.

Authors:  Jerry A Shields; Carol L Shields; Hakan Demirci; Santosh Hanovar
Journal:  Arch Ophthalmol       Date:  2002-03

7.  Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy.

Authors:  Michiyuki Saito; Wataru Saito; Yuki Hashimoto; Chikako Yoshizawa; Akio Fujiya; Kousuke Noda; Susumu Ishida
Journal:  Br J Ophthalmol       Date:  2013-03-26       Impact factor: 4.638

8.  Pulse Waveform Changes in Macular Choroidal Hemodynamics With Regression of Acute Central Serous Chorioretinopathy.

Authors:  Michiyuki Saito; Wataru Saito; Kiriko Hirooka; Yuki Hashimoto; Shohei Mori; Kousuke Noda; Susumu Ishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

9.  Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy.

Authors:  Kiriko Hirooka; Wataru Saito; Yuki Hashimoto; Michiyuki Saito; Susumu Ishida
Journal:  BMC Ophthalmol       Date:  2014-05-28       Impact factor: 2.209

10.  Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.

Authors:  Kanae Fukutsu; Kenichi Namba; Daiju Iwata; Kazuomi Mizuuchi; Satoru Kase; Kayo Suzuki; Hiroshi Shimizu; Yukiko Shibata; Fumihiko Yamawaki; Masahiro Onozawa; Susumu Ishida
Journal:  BMC Ophthalmol       Date:  2020-03-10       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.